• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

FACTORS IMPLICATED IN THE DEVELOPMENT AND RECURRENCE

Research Project

Project/Area Number 12557134
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Obstetrics and gynecology
Research InstitutionTHE UNIVERSITY OF TOKYO

Principal Investigator

TAKETANI Yuji  Faculty of Medicine, Professor, 医学部附属病院, 教授 (10114539)

Co-Investigator(Kenkyū-buntansha) MOMOEDA Mikio  Faculty of Medicine, Research Associate, 医学部附属病院, 助手 (50221627)
KUGU Koji  Faculty of Medicine, Research Associate, 医学部附属病院, 助手 (30322051)
YANO Tetsu  Faculty of Medicine, Lecturer, 医学部附属病院, 講師 (90251264)
OSUGA Yutaka  Faculty of Medicine, Research Associate, 医学部附属病院, 助手 (80260496)
Project Period (FY) 2000 – 2002
Keywordsangiogenesis / endometriosis / cytokine / peritoneal fluid
Research Abstract

To date, numerous soluble substances have been demonstrated to be present at different concentrations with or without endometriosis. We revealed that Stem cell factor (SCF) concentration in PF is increased in women with enodmetriosis. The concentrations of SCF in PF tended to decrease with the progression of endometriosis. SCF is known to stimulate mast cell functions. In view of human endometrium having SCF receptors, it can be speculated that SCF in PF may affect fertility of women with early stages of endometriosis by modulating functions of mast cells and/or endometrial cells. We also detected the increase of sTNFRI and sTNFRII concentrations in PF of women with endometriosis. The increase may stimulate the development of endometriosis, as these soluble molecules may antagonize TNFα mediated apoptosis of endometriotic cells. We further demonstrated that IP-10 concentrations in PF were significantly lower in women with advanced stages of endometriosis as compared to those with early stages. Decreased concentrations of IP-10 in PF from women with advanced stages of endometriosis may imply that the peritoneal environment of these women is permissive to the development of the disease by enhancing angiogenesis and/or modulating inflammatory/ immunological responses.

  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Fujimoto A, Osuga Y, et al.: "Human Chorionic Gonadotropin Combined with Progesterone for Luteal Support Improves Pregnancy Rate in Patients with Low Late-Midluteal Estradiol Levels"J Assist Reprod Genet.. 19・12. 550-554 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fujimoto A, Osuga Y, et al.: "Ovarian hyperstimulation syndrome complicated by peritonitis due to perforated appendicitis"Hum Reprod. 17・4. 966-967 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hiroi H, Osuga Y, et al.: "A case of estrogen-producing brenner tumor with a stromal component as a potential source for estrogen"Oncology. 63. 201-204 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Osuga Y, Yano T, et al.: "Effects of gonadotropin-releasing hormone analog treatment on skin condition"Gynecol Endocrinol. 16. 57-61 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Osuga Y, Koga K, et al.: "Role of laparoscopy in the treatment of endometriosis-associated infertility"Gynecol Obstet Invest. 53・Suppl1. 33-39 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Xu J, Osuga Y, et al.: "Bisphenol A induces apoptosis and G2-to-M arrest of ovarian granulosa cells"Biochem Biophys Res Commun. 292・2. 456-462 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Momoeda M., Taketani Y., Terakawa N., Hoshiai H., Tanaka K., et al.: "Is Endometriosis Really Associated with Pain?"Gynecol Obstet Invest. 54・Suppl1. 18-23 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kurosawa T, Hiroi H, Tsutsumi O, Ishikawa T et al.: "The Activity of Bisphenol A Depends on Both the Estrogen Receptor Subtype and the Cell Type"Endocr J. 49. 465-471 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tang X, Yano T, Osuga Y, et al.: "Cellular Mechanisms of Growth Inhibition of Human Epithelial Ovarian Cancer Cell Line by LH-Releasing Hormone Antagonist Cetrorelix"Cetrorelix J Clin Endocrinol Metab. 87. 3721-3727 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Osuga Y, Koga K, et al.: "Local regulators of the human ovary in associated reproductive technology (ART) in Recent Research Development in Endocrinology (vol.3)"Transworld Research Network. 349-357 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fujimoto A, Osuga Y, Fujiwara T, Yano T, Tsutsumi O, Momoeda M, Kugu K, Koga K, Morita Y, Wada O, Taketani Y.: "Human Chorionic Gonadotropin Combined with Progesterone for Luteal Support Improves Pregnancy Rate in Patients with Low Late-Midluteal Estradiol Levels in IVF Cycles"J Assist Reprod Genet.. 19. 550-554 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Momoeda M, Taketani Y, Terakawa N, Hoshiai H, Tanaka K, Tsutsumi O, Osuga Y, Maruyama M, Harada T, Obafea K, Hayashi K.: "Is endometriosis really associated with pain?"Gynecol Obstet Invest.. 54 Suppl 1. 18-23 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kurosawa T, Hiroi H, Tsutsumi O, Ishikawa T, Osuga Y, Fujiwara T, Inoue S, Muramatsu M, Momoeda M, Taketani Y.: "The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type"Endocr J.. 49. 465-71 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fujimoto A, Osuga Y, Yano T, Kusumi M, Kurosawa T, Fujii T, Taketani Y.: "Ovarian hyperstimulation syndrome complicated by peritonitis due to perforated appendicitis Case Report"Hum Reprod. 17. 966-967 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hiroi H, Osuga Y, Tarumoto Y, Shimokama T, Yano T, Yokota H, Taketani Y.: "A case of estrogen-producing brenner tumor with a stromal component as a potential source for estrogen."Oncology. 63. 201-204 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Osuga Y, Yano T, Kugu K, Koga K, Fukuoka K, Matsumi H, Wada O, Kikuchi A, Tsutsumi O, Taketani Y.: "Effects of gonadotropin-releasirig hormone analog treatment on skin condition."Gynecol Ehdocrinol. 16. 57-61 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Osuga Y, Koga K, Tsutsumi O, Yano T, Maruyama M, Kugu K, Momoeda M, Taketani Y.: "Role of laparoscopy in the treatment of endometriosis-associated infertility."Gynecol Obstet Invest. 53 Suppl 1. 33-39 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tang X, Yano T, Osuga Y, Matsumi H, Yano N, Xu J, Wada O, Koga K, Kugu K, Tsutsumi O, Schally AV, Taketani Y.: "Cellular mechanisms of growth inhibition of human epithelial ovarian cancer cell line by LH-releasing hormone antagonist Cetrorelix"J Clin Endocrinol Metab. 87. 3721-3727 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Xu J, Osuga Y, Yano T, Morita Y, Tang X, Fujiwara T, Takai Y, Matsumi H, Koga K, Taketani Y, Tsutsumi O.: "Bisphenol A induces apoptosis and G2-to-M arrest of ovarian granulosa cells"Biochem Biophys Res Commun. 292. 456-462 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Osuga Y, Koga K, et al: "Transwarld Research Network Local regulators of the human ovary in associated reproductive technology"(ART)in Recent Research Development in Endocrinology. 3. 349-357 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi